CNTX
NASDAQ · Pharmaceuticals
Context Therapeutics Inc
$2.79
-0.39 (-12.26%)
Open$3.22
Previous Close$3.18
Day High$3.33
Day Low$2.70
52W High$22.24
52W Low$14.52
Volume—
Avg Volume86.9K
Market Cap209.48M
P/E Ratio—
EPS$-1.79
SectorPharmaceuticals
Analyst Ratings
Strong Buy
16 analysts
Price Target
+748.7% upside
Current
$2.79
$2.79
Target
$23.68
$23.68
$16.27
$23.68 avg
$31.54
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 27.12M | 24.12M | 28.34M |
| Net Income | 5.84M | 5.30M | 5.57M |
| Profit Margin | 21.6% | 22.0% | 19.7% |
| EBITDA | 7.13M | 6.78M | 8.30M |
| Free Cash Flow | 3.88M | 4.04M | 6.28M |
| Rev Growth | -4.2% | +22.6% | +13.0% |
| Debt/Equity | 1.37 | 0.99 | 1.45 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |